Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$772M |
| 2 |
Eli Lilly
LLY
|
+$337M |
| 3 |
lululemon athletica
LULU
|
+$301M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$297M |
| 5 |
ResMed
RMD
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$576M |
| 2 |
AT&T
T
|
+$476M |
| 3 |
PNC Financial Services
PNC
|
+$393M |
| 4 |
Fortive
FTV
|
+$389M |
| 5 |
Accenture
ACN
|
+$374M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.83% |
| 2 | Technology | 2.79% |
| 3 | Financials | 2.29% |
| 4 | Consumer Discretionary | 1.93% |
| 5 | Industrials | 1.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3451
Oxford Industries
OXM
$543M
| $5.73M | ﹤0.01% |
64,604
+23,023
| +55% | +$2.07M |
|
3452
DXC Technology
DXC
$1.72B
| $5.73M | ﹤0.01% |
189,048
-642,674
| -77% | -$19.9M |
|
3453
Global X Lithium & Battery Tech ETF
LIT
$1.61B
| $5.72M | ﹤0.01% |
78,737
+25,691
| +48% | +$1.83M |
|
|
CSII
3454
DELISTED
Cardiovascular Systems, Inc.
CSII
| $5.71M | ﹤0.01% |
397,803
-573,354
| -59% | -$9.95M |
|
3455
CALL
GXO Logistics
GXO
$5.59B
| $5.71M | ﹤0.01% |
131,900
-62,900
| -32% | -$3.48M |
|
3456
PUT
SSR Mining
SSRM
$6.56B
| $5.7M | ﹤0.01% |
341,500
+51,900
| +18% | +$1.07M |
|
3457
Blue Owl Capital
OWL
$19.1B
| $5.7M | ﹤0.01% |
567,927
-380,186
| -40% | -$4.56M |
|
3458
CALL
Shift4
FOUR
$3.58B
| $5.69M | ﹤0.01% |
172,100
-76,600
| -31% | -$3.62M |
|
3459
PUT
VeriSign
VRSN
$25.7B
| $5.69M | ﹤0.01% |
34,000
+21,000
| +162% | +$3.85M |
|
|
FPI
3460
Farmland Partners
FPI
$433M
| $5.69M | ﹤0.01% |
412,124
+142,489
| +53% | +$2.07M |
|
3461
Brookdale Senior Living
BKD
$3.02B
| $5.69M | ﹤0.01% |
1,252,370
+24,767
| +2% | +$146K |
|
3462
CALL
Cheesecake Factory
CAKE
$5.64B
| $5.69M | ﹤0.01% |
215,200
+30,500
| +17% | +$1.01M |
|
|
IAA
3463
CALL
DELISTED
IAA, Inc. Common Stock
IAA
| $5.69M | ﹤0.01% |
173,500
-41,500
| -19% | -$1.52M |
|
3464
Alignment Healthcare
ALHC
$2.9B
| $5.68M | ﹤0.01% |
497,542
-93,743
| -16% | -$989K |
|
3465
CALL
Molina Healthcare
MOH
$11.1B
| $5.68M | ﹤0.01% |
20,300
-8,200
| -29% | -$2.48M |
|
3466
Companhia Siderúrgica Nacional
SID
$1.17B
| $5.67M | ﹤0.01% |
1,936,773
+1,504,289
| +348% | +$6.34M |
|
3467
CALL
Corpay
CPAY
$27.4B
| $5.67M | ﹤0.01% |
27,000
-32,000
| -54% | -$7.62M |
|
|
SUMO
3468
DELISTED
Sumo Logic, Inc. Common Stock
SUMO
| $5.67M | ﹤0.01% |
757,046
+352,841
| +87% | +$3.09M |
|
3469
Vericel Corp
VCEL
$2.26B
| $5.67M | ﹤0.01% |
225,202
+207,792
| +1,194% | +$6.14M |
|
3470
Sibanye-Stillwater
SBSW
$7.62B
| $5.67M | ﹤0.01% |
568,513
+378,490
| +199% | +$4.94M |
|
3471
CALL
Packaging Corp of America
PKG
$22.8B
| $5.67M | ﹤0.01% |
41,200
-12,100
| -23% | -$1.87M |
|
3472
DraftKings
DKNG
$13B
| $5.66M | ﹤0.01% |
484,827
-1,485,457
| -75% | -$20.9M |
|
3473
Veracyte
VCYT
$3.32B
| $5.66M | ﹤0.01% |
284,137
+107,769
| +61% | +$2.18M |
|
3474
Alphatec Holdings
ATEC
$1.51B
| $5.65M | ﹤0.01% |
864,222
+284,206
| +49% | +$2.62M |
|
3475
New York Times
NYT
$10.4B
| $5.65M | ﹤0.01% |
+202,571
| New | +$7.32M |
|
Similar funds
Ken Griffin's Q2 2022 Portfolio in Review
As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.
By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.
- Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
- Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
- Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
- Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
- Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
- Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
- Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.
Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.